Effect of clindamycin treatment on vaginal inflammatory markers in pregnant women with bacterial vaginosis and a positive fetal fibronectin test

Abstract

Objective To compare the levels of interleukin (IL)-1β, IL-6, and matrix metalloproteinase (MMP)-8 in the vaginal secretions of pregnant women with a positive fetal fibronectin (fFN) test result with or without asymptomatic bacterial vaginosis (BV) before and after treatment with oral clindamycin. Methods A prospective cohort study was conducted among 43 pregnant women with a positive fFN test result. All patients were treated with clindamycin, and the pre- and post-treatment levels of IL-1β, IL-6, and MMP-8 were compared. Results Before treatment, levels of IL-1β and MMP-8 were significantly higher in women with BV compared with women without BV ( P < 0.05). Vaginal levels of IL-1β and IL-6, but not MMP-8, decreased after treatment in pregnant women with BV. Conclusions The inability of clindamycin to decrease MMP-8 vaginal levels may explain why it is ineffective in reducing preterm birth in pregnant women with positive fFN and BV.